Therapeutischer „Trip“?

A discourse with Henrik Jungaberle from the MIND Foundation (Berlin)

The Berlin-based MIND Foundation is committed to the medical research into substances such as psilocybin and MDMA. and is part of the first German study with psilocybin for depression. for depression. One of their core questions is: How can psychedelics help to heal and learn? We talk to Henrik Jungaberle, director of the MIND Foundation, about How psychedelics work and how they are accepted, and about risks, limitations, and potentials of their use in and outside of therapy.